Sangeeta Hingorani1, Emily Pao2, Gary Schoch3, Ted Gooley3, George J Schwartz4. 1. Seattle Children's Hospital, University of Washington Seattle, Washington; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington; and sangeeta.hingorani@seattlechildrens.org. 2. Seattle Children's Hospital, University of Washington Seattle, Washington; 3. Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington; and. 4. Division of Pediatric Nephrology, University of Rochester, Rochester, New York.
Abstract
BACKGROUND AND OBJECTIVES: Formal evaluation of kidney function before and after hematopoietic cell transplant is important to determine conditioning regimens, type of transplant, and medication dosing. Serum creatinine and estimating equations may not accurately assess kidney function. DESIGN, STUDY, PARTICIPANTS, & MEASUREMENTS: Existing estimating equations for GFR were compared with an iohexol measure of GFR in a prospective cohort study of 50 patients undergoing hematopoietic cell transplant and subsequent care at the Fred Hutchinson Cancer Research Institute from 2009 to 2013. Patients underwent iohexol GFR, serum creatinine, and cystatin C determination at baseline and day 100 posthematopoietic cell transplant. Iohexol GFR measurements were compared with the CKD Epidemiology Collaboration, Inker CKD Epidemiology Collaboration cystatin C with and without serum creatinine, Modification of Diet in Renal Disease, and Cockcroft-Gault estimating equations using Bland-Altman analysis and McNemar's test. The iohexol measurements were also compared with blood samples collected simultaneously on filter paper. RESULTS: Mean differences between iohexol GFR and eGFR on the basis of Bland-Altman analyses ranged from -20.6 to +15.4 ml/min per 1.73 m(2) at baseline and -12.7 to +12.9 ml/min per 1.73 m(2) at day 100. The CKD Epidemiology Collaboration and Modification of Diet in Renal Disease estimating equations classified 64% of patients with a GFR<90 at baseline compared with 38% by iohexol GFR (P=0.003 and P<0.01, respectively). No statistically significant differences were seen at day 100. The filter paper GFR had a mean difference of 0 at baseline and 5.9 at day 100. Additionally, 21%-37% and 57%-89% of eGFRs were within 10% and 30%, respectively, of the iohexol GFR at baseline, and 16%-34% and 72%-84% were within 10% and 30%, respectively, of the iohexol GFR at day 100; 98% of the filter paper estimates at baseline were within 30%, and 46% were within 10% of iohexol GFR. CONCLUSIONS: The estimating equations are neither accurate nor precise in the hematopoietic cell transplant population, and clinical decision may require measurement of GFR.
BACKGROUND AND OBJECTIVES: Formal evaluation of kidney function before and after hematopoietic cell transplant is important to determine conditioning regimens, type of transplant, and medication dosing. Serum creatinine and estimating equations may not accurately assess kidney function. DESIGN, STUDY, PARTICIPANTS, & MEASUREMENTS: Existing estimating equations for GFR were compared with an iohexol measure of GFR in a prospective cohort study of 50 patients undergoing hematopoietic cell transplant and subsequent care at the Fred Hutchinson Cancer Research Institute from 2009 to 2013. Patients underwent iohexolGFR, serum creatinine, and cystatin C determination at baseline and day 100 posthematopoietic cell transplant. IohexolGFR measurements were compared with the CKD Epidemiology Collaboration, Inker CKD Epidemiology Collaboration cystatin C with and without serum creatinine, Modification of Diet in Renal Disease, and Cockcroft-Gault estimating equations using Bland-Altman analysis and McNemar's test. The iohexol measurements were also compared with blood samples collected simultaneously on filter paper. RESULTS: Mean differences between iohexolGFR and eGFR on the basis of Bland-Altman analyses ranged from -20.6 to +15.4 ml/min per 1.73 m(2) at baseline and -12.7 to +12.9 ml/min per 1.73 m(2) at day 100. The CKD Epidemiology Collaboration and Modification of Diet in Renal Disease estimating equations classified 64% of patients with a GFR<90 at baseline compared with 38% by iohexolGFR (P=0.003 and P<0.01, respectively). No statistically significant differences were seen at day 100. The filter paper GFR had a mean difference of 0 at baseline and 5.9 at day 100. Additionally, 21%-37% and 57%-89% of eGFRs were within 10% and 30%, respectively, of the iohexolGFR at baseline, and 16%-34% and 72%-84% were within 10% and 30%, respectively, of the iohexolGFR at day 100; 98% of the filter paper estimates at baseline were within 30%, and 46% were within 10% of iohexolGFR. CONCLUSIONS: The estimating equations are neither accurate nor precise in the hematopoietic cell transplant population, and clinical decision may require measurement of GFR.
Authors: Srinivasan Beddhu; Matthew H Samore; Mark S Roberts; Gregory J Stoddard; Lisa M Pappas; Alfred K Cheung Journal: J Am Soc Nephrol Date: 2003-04 Impact factor: 10.121
Authors: G Visvardis; I Griveas; R Zilidou; D Papadopoulou; E Mitsopoulos; P Kyriklidou; E Manou; E Ginikopoulou; D Meimaridou; A Pavlitou; G Sakellariou Journal: Transplant Proc Date: 2004 Jul-Aug Impact factor: 1.066
Authors: Penny Whiting; Kate Birnie; Jonathan A C Sterne; Catherine Jameson; Rod Skinner; Bob Phillips Journal: Support Care Cancer Date: 2017-12-06 Impact factor: 3.603
Authors: M Joannidis; S J Klein; S John; M Schmitz; D Czock; W Druml; A Jörres; D Kindgen-Milles; J T Kielstein; M Oppert; V Schwenger; C Willam; A Zarbock Journal: Med Klin Intensivmed Notfmed Date: 2018-03-28 Impact factor: 0.840
Authors: Philip Roland Selby; Sepehr Shakib; Sandra L Peake; Morgyn S Warner; David Yeung; Uwe Hahn; Jason A Roberts Journal: Clin Pharmacokinet Date: 2021-01-30 Impact factor: 6.447
Authors: Sangeeta Hingorani; Emily Pao; Phil Stevenson; Gary Schoch; Benjamin L Laskin; Ted Gooley; George B McDonald Journal: Clin J Am Soc Nephrol Date: 2018-04-18 Impact factor: 8.237